Despite Business Halt Order, Taiyo Projects Double-digit Growth For 2010
This article was originally published in PharmAsia News
Executive Summary
Nagoya-based generic drug maker Taiyo Pharmaceutical said the temporary halt of production will have little impact on its financial results for FY2010